Bertram Köhler
Chief Executive Officer at DEUTSCHE EFFECTEN- UND WECHSEL-BETEILIGUNGSGESELLSCHAFT AG
Network origin in Bertram Köhler first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Biotechnology | 12 | |
Public Company | Financial Conglomerates | 10 | |
10
| Public Company | Finance/Rental/Leasing | 10 |
NOXXON Pharma AG
NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany.
9
| Subsidiary | Biotechnology | 9 |
DEWB AG (Venture Capital)
DEWB AG (Venture Capital) Investment ManagersFinance DEWB AG (Venture Capital) (DEWB-VC) is the venture capital subsidiary of Deutsche Effecten & Wechsel Beteiligungs AG (FR: EFF), headquartered in Jena, Germany. The firm, established in 1997, provides equity capital, corporate development expertise and network support to strong growth, medium-sized technology companies.
8
| Operating Division | Investment Managers | 8 |
LemnaTec GmbH
LemnaTec GmbH Medical SpecialtiesHealth Technology LemnaTec GmbH develops research platforms and analysis software for agricultural chemistry, plant cultivation, biotechnology, and pharmacy. It generates reproducible and scientifically sound images in light wavelengths. The firm develops also imaging, image analysis automatisation, and data handling modules. The company was founded by Dirk Vandenhirtz and Matthias Eberius in 1998 and is headquartered in Aachen, Germany.
1
| Subsidiary | Medical Specialties | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Bertram Köhler via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
MVISE AG | Packaged Software | Chairman Director/Board Member | |
Autonomic Technologies, Inc.
Autonomic Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA. | Electronic Equipment/Instruments | Director/Board Member | |
L-KONZEPT HOLDING AG | Real Estate Development | Chairman Chairman | |
EVOTEC SE | Pharmaceuticals: Major | Chairman Director/Board Member | |
Netrada Holding GmbH
Netrada Holding GmbH Advertising/Marketing ServicesCommercial Services Netrada Holding GmbH provides fashion e-commerce, customer contact management, mobile, and telephone services. It also specializes in online shop setup and content management via photography, video production, digital marketing, customer care and warehousing logistics, as well as payment and collection services. The company was founded in 1984 and is headquartered in Hamburg, Germany. | Advertising/Marketing Services | Chief Executive Officer Director of Finance/CFO | |
Kreos Capital Management (UK) Ltd.
Kreos Capital Management (UK) Ltd. Investment ManagersFinance Kreos Capital Management (UK) Ltd (Kreos Capital) is a private equity firm founded in 1998. The firm is headquartered in London with additional offices in Israel, Sweden, Jersey and Luxembourg. | Investment Managers | Private Equity Investor | |
Shire Orphan Therapies GmbH
Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
SMARTRAC TECHNOLOGY Dresden GmbH
SMARTRAC TECHNOLOGY Dresden GmbH Electronic Production EquipmentElectronic Technology SMARTRAC TECHNOLOGY Dresden GmbH engages in the design, manufacture, and testing of electronic and electromechanical components, particularly miniaturized components. It specializes in technologies for the production of electronic circuit boards, installation of microassemblies, as well as the development and manufacture of equipment for the production and testing of microasseblies. The company was founded in November 1994 and is headquartered in Dresden, Germany. | Electronic Production Equipment | Chairman Corporate Officer/Principal Director/Board Member | |
Roche Diagnostics GmbH
Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
INSEAD | College/University | Masters Business Admin Masters Business Admin | |
Horizon Therapeutics Switzerland GmbH
Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
University of Utrecht | College/University | Doctorate Degree Doctorate Degree | |
LAIQON AG | Investment Trusts/Mutual Funds | Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
ACTIVA RESOURCES AG | Integrated Oil | Chairman | |
SUPERSONIC IMAGINE | Medical Specialties | Director/Board Member | |
Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Doctorate Degree | |
VIVORYON THERAPEUTICS N.V. | Biotechnology | Director/Board Member Director/Board Member | |
Biotech Venture Management LLC | Corporate Officer/Principal | ||
IMPLANET SA | Medical Specialties | Director/Board Member | |
Opsona Therapeutics Ltd.
Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member | |
TUDAG TU Dresden AG
TUDAG TU Dresden AG Miscellaneous Commercial ServicesCommercial Services TUDAG TU Dresden AG engages in the transfer and exchange of scientific knowledge through academic education, research and development, project management, as well as spin-offs and start ups. Its services also include carrying out of pilot developments, organizing forums, development projects, and consulting. The company was founded on December 21, 1999 and is headquartered in Dresden, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
AKTIENMAR | Financial Conglomerates | Chairman Chief Executive Officer Chief Executive Officer | |
Powerparc AG
Powerparc AG Engineering & ConstructionIndustrial Services Powerparc AG operates as a building equipment contractor. The company is headquartered in Frankfurt, Germany. | Engineering & Construction | Director/Board Member | |
Zweite DEWB Vermögensverwaltungs AG | Chairman Director/Board Member Director/Board Member | ||
ISOFOL MEDICAL AB | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
European Space Innovation AG | General Government | Chairman Chairman | |
JenaValve Technology, Inc.
JenaValve Technology, Inc. Medical SpecialtiesHealth Technology JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE. | Medical Specialties | Director/Board Member | |
eventa AG | Chairman Director/Board Member | ||
Medlumics SL
Medlumics SL Medical SpecialtiesHealth Technology Medlumics SL provides medical imaging diagnostics services. It specializes in optically guided medical devices. The firm’s proprietary integrated optics platform technology combines optical and electrical components in a miniature chip, enabling for the first time complex multi view optical probes of the size of a grain of rice and ultra-portable, hand-held OCT systems that produces real-time images. The company was founded by Eduardo Margallo Balbás and Jose Luis Rubio Guivernau on April 3, 2009 and is headquartered in Tres Cantos, Spain. | Medical Specialties | Director/Board Member | |
SPSW Capital GmbH
SPSW Capital GmbH Investment ManagersFinance SPSW Capital GmbH operates as a a bank-independent investor. It manages both the assets of the founders as well as foreign capital in currently two public and a hedge fund. The company was founded by Achim Plate, Robert Suckel and Henning Soltau in 2010 and is headquartered in Hamburg, Germany. | Investment Managers | Chief Executive Officer Chief Executive Officer | |
HighLife SAS
HighLife SAS Medical SpecialtiesHealth Technology HighLife SAS develops percutaneous mitral valve replacement therapies. It offers a minimally invasive prosthetic mitral valve that is implanted on a beating heart, while preserving the native valve structure and respecting the surrounding anatomy. The company was founded by Georg Börtle in 2010 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member | |
BTBS Born to be styled AG | Chairman Chairman | ||
Institut Für Medizinische Mikrobiologie | College/University | Doctorate Degree | |
DECIMO GmbH
DECIMO GmbH Finance/Rental/LeasingFinance DECIMO GmbH engages in the provision of bill management services. It offers factoring and invoice management services to entrepreneurs, freelancers, and small companies; and provides debt collection services. The company was founded by Andreas Dubrow and Philipp Kalwies on December 22, 2011 and is headquartered in Berlin, Germany. | Finance/Rental/Leasing | Chief Executive Officer Chief Executive Officer Chief Operating Officer | |
SPSW Capital Investment-AG TGV
SPSW Capital Investment-AG TGV Financial ConglomeratesFinance Part of Laiqon AG, SPSW Capital Investment-AG TGV is a German company that provides investment and investment management services. The company is based in Hamburg, Germany. The CEOs of the company are Robert Suckel, Achim Plate, Henning Soltau. | Financial Conglomerates | Chief Executive Officer Chief Executive Officer | |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | Biotechnology | Director-Back Office Operation | |
aifinyo finance GmbH
aifinyo finance GmbH Financial ConglomeratesFinance Part of aifinyo AG, aifinyo finance GmbH is a German B2B-Fintech company that enables personal recruiters and recruiters to manage invoices, financing, and cash flow on a single platform. The company is based in Dresden, Germany. The CEOs are Stefan Kempf, Matthias Andreas Bommer. The company was founded in 1998. | Financial Conglomerates | Chief Executive Officer Chief Executive Officer | |
Elbe Inkasso GmbH | Chief Executive Officer Chief Executive Officer | ||
aifinyo finetrading GmbH
aifinyo finetrading GmbH Wholesale DistributorsDistribution Services Aifinyo Finetrading GmbH is a German company that wholesales household goods. The private company is based in Dresden, Germany. The CEOs are Matthias Andreas Bommer, Stefan Kempf. The company was founded in 2014. | Wholesale Distributors | Chief Executive Officer Chief Executive Officer | |
T-Knife GmbH
T-Knife GmbH BiotechnologyHealth Technology T-Knife GmbH operates as an next-generation adoptive T-cell company using its proprietary humanized T-cell receptor mouse platform to treat solid tumors. The company was founded by Thomas Blankenstein, Elisa Kieback and Holger Specht in 2018 and is headquartered in Berlin, Germany. | Biotechnology | Director/Board Member | |
MINERALYS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
DARWIN AG | Biotechnology | Corporate Officer/Principal Director/Board Member | |
Ariceum Therapeutics GmbH
Ariceum Therapeutics GmbH Miscellaneous Commercial ServicesCommercial Services Ariceum Therapeutics GmbH is a German clinical stage radiopharmaceutical company that focuses on the diagnosis and precision treatment of certain neuroendocrine and other aggressive, hard-to-treat cancers. Ariceum Therapeutics is based in Berlin, DE, and has subsidiaries in various locations worldwide. The company's lead targeted systemic radiopharmaceutical product, -satoreotide tetraxetan ("satoreotide"), is an antagonist of the somatostatin type 2 (sstr2) receptor, which is overexpressed in neuroendocrine tumors (NETs) and some aggressive cancers such as small cell lung cancer (SCLC) and Merkel cell carcinoma. Ariceum is also developing a radiolabeled PARP-inhibitor (ATT-001), which is slated to enter the clinic in early 2024. The company was founded in 2021, and Manfred Rüdiger has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
JENOPTIK siebente Vermögens AG | Chairman Director/Board Member Director/Board Member |
Statistics
International
Germany | 30 |
France | 7 |
United States | 5 |
Switzerland | 5 |
United Kingdom | 2 |
Sectoral
Health Technology | 19 |
Finance | 9 |
Commercial Services | 5 |
Consumer Services | 5 |
Electronic Technology | 4 |
Operational
Director/Board Member | 170 |
Chairman | 65 |
Corporate Officer/Principal | 53 |
Chief Executive Officer | 44 |
Independent Dir/Board Member | 25 |
Most connected contacts
Insiders | |
---|---|
Joseph deBethizy | 29 |
Hubert Birner | 27 |
Denis Lucquin | 26 |
Markus W. Wenner | 23 |
Gregory Weaver | 22 |
Olivier Litzka | 21 |
Gerhard Fettweis | 20 |
Peter Johann | 18 |
Jarl Ulf Birger Jungnelius | 16 |
Thomas Kordick | 14 |
Walter Wenninger | 14 |
Florian Renner | 12 |
Achim Plate | 11 |
Aram Andrew Mangasarian | 11 |
Susan Coles | 10 |
- Stock Market
- Insiders
- Bertram Köhler
- Company connections